EMA Seeks Comments on Advanced Therapy Trials

Drug Industry Daily
A A
European regulators on Thursday asked for public comment on new guidelines for advanced therapies, especially for first-in-human trials.

To View This Article:

Login

Subscribe To Drug Industry Daily